Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Ajooni Biotech
Small Cap•134 Employees•IPO 2018
Current Price
₹4.15
-0.29 (-6.53%)Updated
Today's Range
4.1
₹4.15
4.41
52 Week Range
52W Low₹3.55
52W High₹6.85
₹4.15
Downside16.90%
Upside65.06%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹85.95 Cr
Market Cap
Total market value of companyP/E Ratio
17.47
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
0.81
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹0.32
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
5.50%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
6.91%
ROCE
Return on Capital Employed. >15% is goodNet Margin
3.45%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-12.25%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
23.43%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
21.90%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
66.00%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.02
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹5.11
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
26.90%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
5 points- •Robust 66.00% quarter-on-quarter profit growth indicates improving operational efficiency.
- •Solid 21.90% increase in quarterly sales reflects positive market traction.
Weaknesses
5 points- •Low Return on Capital Employed (ROCE 6.91%) and ROE (5.15%) indicate inefficient capital utilization.
- •Promoter holding significantly decreased from 52.62% to 26.89%, signaling potential concern.
Opportunities
4 points- •Operates in Animal Feed industry, part of FMCG, suggesting sustained demand.
- •Opportunity to diversify into related products like pet food or organic feed.
Threats
4 points- •Significant competition from larger, more profitable peers like Godrej Agrovet.
- •Dependency on raw materials exposes company to price volatility, squeezing margins.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹4.96 | +₹0.81 | +19.52% |
| R3 | ₹4.65 | +₹0.50 | +12.05% |
| R2 | ₹4.53 | +₹0.38 | +9.16% |
| R1 | ₹4.34 | +₹0.19 | +4.58% |
| PIVOT | ₹4.22 | 0.07 | 1.69% |
| CURRENT | ₹4.15 | - | - |
| S1 | ₹3.41 | -₹0.74 | -17.83% |
| S2 | ₹3.72 | -₹0.43 | -10.36% |
| S3 | ₹3.91 | -₹0.24 | -5.78% |
| S4 | ₹4.03 | -₹0.12 | -2.89% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+39.0% vs avg
6.06L
(13 Mar 2026)Delivery %+14.0% vs avg
78.2%
(13 Mar 2026)Avg Volume (20D)20-day average
4.36L
(13 Feb - 13 Mar)Avg Delivery %Trend ↑
64.2%
(13 Feb - 13 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Godrej Agrovet Ltd
12,413.88 ₹ Cr
Best Profit Growth
Godrej Agrovet Ltd
18.80 %
Highest Dividend Yield
Godrej Agrovet Ltd
1.70 %
Peer Comparison
| Company Name |
|---|
 Godrej Agrovet Ltd |
 Narmada Agrobase Ltd |
 Shreeoswal Seeds & Chemicals Ltd |
About
Ajooni Biotech Ltd
Ajooni Biotech Limited is an Indian company specializing in the manufacturing and sale of cattle feed. Established in 2010 and headquartered in Mohali, India, the company caters to the significant livestock feed market within the country. Their business model centers around providing a range of products designed to meet the nutritional needs of various animals.
The company's product portfolio demonstrates a commitment to diverse livestock feed requirements. They offer cattle feed chips as a core product, targeting the large cattle farming sector in India. Recognizing the importance of other livestock, they also produce camel feed, catering to a niche but vital part of the agricultural landscape. Furthermore, their product line includes cotton oil cakes and mustard oil cakes, which serve as cost-effective and nutritious supplementary feed components for various animals.
Beyond the primary feed products, Ajooni Biotech Limited also supplies feed supplements. These supplements are likely formulated to address specific nutritional deficiencies or enhance the overall health and productivity of the livestock. The inclusion of supplements demonstrates a focus on providing complete and balanced nutrition solutions, thereby enhancing the value proposition for their customers.
The overall business strategy appears to be centered on providing a comprehensive range of livestock feed products to meet the diverse needs of the Indian agricultural market. By offering both primary feed sources and essential supplements, Ajooni Biotech Limited aims to establish itself as a reliable and versatile supplier within the competitive Indian cattle feed industry. Their presence in Mohali provides a strategic location for distribution and access to key agricultural regions.
COMPANY FACTS - AJOONI
Registered Address
D-118, Industrial Area,, Phase - 7,
Mohali
PUNJAB
IN
Tel: 911725020762
Website:https://www.ajoonibiotech.com/
Investor Relations:https://www.ajoonibiotech.com/Home/AnnualReport
Company Details
Group: Food, Beverage & Tobacco
Sector: Consumer Staples
Industry: Food Products
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 134
IPO Date: 02/01/2018
MANAGEMENT - AJOONI
Mr. Charanjit Singh
Chief Financial Officer
Mr. Sandeep Goyal
Compliance Officer, Company Secretary
Mr. Jasjot Singh
Managing Director, Executive Director
Mr. Partek Singh
Executive and Non Independent Director
Mr. Imteshwar Bhatia
Non-Executive Independent Director
Mr. Ishtneet Bhatia
Independent Non-Executive Director
Ms. Simmi Chhabra
Non-Executive Independent Director
Mr. Ramandeep Singh
Non-Executive Independent Director
Investor Questions Answered
Ajooni Biotech Ltd (AJOONI) Stock FAQs
Get answers to the most common questions about Ajooni Biotech Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Ajooni Biotech Ltd (AJOONI) is ₹4.15. Today, the stock has declined by ₹0.29 (6.53%), trading in a range of ₹4.1 to ₹4.41. The stock opened at ₹4.39 with a trading volume of 6,05,507 shares.
Ajooni Biotech Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹85.95 crores, P/E ratio of 17.47, ROE of 5.50%, and ROCE of 6.91%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Ajooni Biotech Ltd (AJOONI) is ₹6.85, while the 52-week low is ₹3.55. Currently trading at ₹4.15, the stock is 18.2% away from its 52-week low and 39.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Ajooni Biotech Ltd stock at ₹4.15 depends on multiple factors. The stock is currently trading with a P/E ratio of 17.47 and P/B ratio of N/A. Today's performance shows a loss of 6.53%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Ajooni Biotech Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹4.15, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Ajooni Biotech Ltd's key financial metrics include: P/E Ratio: 17.47, P/B Ratio: N/A, ROE: 5.50%, ROCE: 6.91%, Dividend Yield: 0.00%, EPS: ₹0.32, Book Value: ₹5.11, Debt-to-Equity: 0.02, and Current Ratio: N/A. The company's market cap stands at ₹85.95 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Ajooni Biotech Ltd stock opened at ₹4.39 and is currently trading at ₹4.15, showing a decline of ₹0.29 (6.53%). The intraday high is ₹4.41 and low is ₹4.1. The trading volume stands at 6,05,507 shares, indicating moderate market participation today.
Ajooni Biotech Ltd has a Price-to-Earnings (P/E) ratio of 17.47, which means investors are willing to pay ₹17.47 for every ₹1 of earnings. With an EPS of ₹0.32, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Ajooni Biotech Ltd has a market capitalization of ₹85.95 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹4.15) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Ajooni Biotech Ltd has a book value of ₹5.11 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹4.15, which is 18.8% below the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Ajooni Biotech Ltd has a Return on Equity (ROE) of 5.50% and Return on Capital Employed (ROCE) of 6.91%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Ajooni Biotech Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Ajooni Biotech Ltd has a debt-to-equity ratio of 0.02, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Ajooni Biotech Ltd has an Earnings Per Share (EPS) of ₹0.32, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹4.15 and P/E ratio of 17.47, investors are paying 17.47 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Ajooni Biotech Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Ajooni Biotech Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Ajooni Biotech Ltd stock, consider: 1) Fundamental Analysis - Review P/E (17.47), ROE (5.50%), debt-to-equity (0.02), and growth rates. 2) Technical Analysis - Check 52-week range (₹3.55 - ₹6.85), moving averages, and chart patterns. 3) Valuation - Compare current price (₹4.15) with book value (₹5.11) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Ajooni Biotech Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹4.15 is 108x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Ajooni Biotech Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹3.55 - ₹6.85). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.02 indicates leverage. 4) Liquidity Risk - Based on trading volume of 6,05,507 shares. 5) Valuation Risk - P/E of 17.47 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Ajooni Biotech Ltd operates in the industry with key metrics: P/E ratio of 17.47, ROE of 5.50%, market cap of ₹85.95 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.02), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Ajooni Biotech Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹4.15, with a 52-week range of ₹3.55 to ₹6.85. Based on fundamentals like P/E (17.47), ROE (5.50%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Ajooni Biotech Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹4.15. 2) Fundamental Deterioration - Declining ROE (currently 5.50%), increasing debt (D/E: 0.02), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Ajooni Biotech Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu